When is it the right time to use tyrosine kinase inhibitors in the era of IO for lung cancer?
Bildiriler · 2018
Yazarlar: Burcu ÇAKAR
Primo Meeting (Practical Recommendations in Immuno and Molecular Oncology 2018), Türkiye, Nevşehir, Uluslararası, Davetli Konuşmacı, 2018-2018